Phase 1 study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer Meeting Abstract


Authors: Laetsch, T. W.; Nagasubramanian, R.; Dubois, S. G.; Mascarenhas, L.; Hawkins, D.; Shukla, N.; Turpin, B.; Smith, S.; Reynolds, M.; Cruickshank, S.; Donahue, L.; Cox, M. C.; Pappo, A.
Abstract Title: Phase 1 study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer
Meeting Title: 41st European Society for Medical Oncology Congress (ESMO)
Journal Title: Annals of Oncology
Volume: 27
Issue: Suppl. 6
Meeting Dates: 2016 Oct 7-11
Meeting Location: Copenhagen, Denmark
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2016-10-01
Start Page: vi131
Language: English
ACCESSION: WOS:000393912500405
DOI: 10.1093/annonc/mdw368.50
PROVIDER: wos
Notes: Meeting Abstract: 407TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neerav Shukla
    159 Shukla